Loss of heterozygosity on chromosome 17 and mutation of the p53 gene in retinoblastoma

Cancer Letters

Volumn 106, Issue 1, 1996, Pages 75-82

  Kato, Mitsuo V ^a,b   Shimizu, Takashi ^b   Ishizaki, Kanji ^c   Kaneko, Akihiro ^d   Yandell, David W ^e   Toguchida, Junya ^b   Sasaki, Masao S ^b  

^a RIKEN TSUKUBA INSTITUTE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL   (Japan)

^e UNIVERSITY OF VERMONT   (United States)

Author keywords

Chromosome 17; Loss of heterozygosity; p53; Retinoblastoma

Indexed keywords

PROTEIN P53;

ARTICLE; CHROMOSOME 17P; CLINICAL ARTICLE; FAMILIAL CANCER; HETEROZYGOSITY; HUMAN; HUMAN CELL; LUNG METASTASIS; POINT MUTATION; PRIORITY JOURNAL; RETINOBLASTOMA; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR SUPPRESSOR GENE;

EID: 0030598937     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04305-4     Document Type: Article

References (24)

1. [1] Greenblatt, M.S., Bennett, W.P., Hollstein, M. and Harris, C.C. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878.
2. [2] Knudson, Jr., A.G. (1985) Hereditary cancer, oncogenes and antioncogenes. Cancer Res., 45, 1437-1443.
3. [3] Malkin, D., Li, F.P., Strong, L.C., Fraumeni, J.J., Nelson, C.E., Kim, D.H., Kassel, J., Gryka, M.A., Bischoff, F.Z., Tainsky, M.A. and Friend, S.H. (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science, 250, 1233-1238.
4. [4] Srivastava, S., Zou, Z.Q., Pirollo, K., Blattner, W. and Chang, E.H. (1990) Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature, 348, 747-749.
5. [5] Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montogomery, Jr., C.A., Butel, J.S. and Bradley, A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature, 356, 215-221.
6. [6] Horsthemke, B. (1992) Genetics and cytogenetics of retinoblastoma. Cancer Genet. Cytogenet., 63, 1-7.
7. [7] Hovig, E., Andreassen, A., Fangan, B.M. and Borresen, A.L. (1992) A TP53 mutation detected in cells established from an osteosarcoma, but not in the retinoblastoma of a patient with bilateral retinoblastoma and multiple primary osteosarcomas. Cancer Genet. Cytogenet., 64, 178-182.
8. [8] Howes, K.A., Ransom, N., Papermaster, D.S., Lasudry, J.G.H., Albert, D.M. and Windle, J.J. (1994) Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev., 8, 1300-1310.
9. [9] Kato, M.V., Ishizaki, K., Ejima, Y., Kaneko, A., Tanooka, H. and Sasaki, M.S. (1993) Loss of heterozygosity on chromosome 13 and its association with delayed growth of retinoblastoma. Int. J. Cancer, 54, 922-926.
10. [10] Kato, M.V., Ishizaki, K., Toguchida, J., Kaneko, A., Takayama, J., Tanooka, H., Kato, T., Shimizu, T. and Sasaki, M.S. (1994) Mutations in the retinoblastoma gene and their expression in somatic and tumor cells of patients with hereditary retinoblastoma. Hum. Mutat., 3, 44-51.
11. [11] Reese, A.B. (1976) Tumors in the Eye, 3rd edn., pp. 90-124. Harper and Row, New York.
12. [12] Sambrook, J., Fritch, J. and Maniatis, T. (1989) Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
13. [13] Harlow, E., Williamson, N.M., Ralston, R., Helfman, D.M. and Adams, T.E. (1985) Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53. Mol. Cell. Biol., 5, 1601-1610.
14. [14] Nakamura, Y., Lathrop, M., O'Connell, P., Leppert, M., Barker, D., Wright, E., Skolnick, M., Kondoleon, S., Litt, M., Lalouel, J. and White, R. (1988) A mapped set of DNA markers for human chromosome 17. Genomics, 2, 302-309.
15. [15] Fain, P.R. (1992) Third International Workshop on Human Chromosome 17 Mapping. Cytogenet. Cell Genet., 60, 178-186.
16. [16] Toguchida, J., Yamaguchi, T., Ritchie, B., Beauchamp, R.L., Dayton, S.H., Herrera, G.E., Yamumuro, T., Kotoura, Y., Sasaki, M.S., Little, J.B., Weichsellbaum, R.R., Ishizaki, K. and Yandell, D.W. (1992) Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res., 52, 6194-6199.
17. [17] Harlow, E. (1992) Retinoblastoma: for our eyes only. Nature, 359, 270.
18. [18] Oliner, J.D., Kinzler, K.W., Meltzer, P.S., George, D.L. and Vogelstein, B. (1992) Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature, 358, 80-83.
19. [19] Kato, M.V., Ishizaki, K., Shimizu, T., Toguchida, J., Kaneko, A. and Sasaki, M.S. (1995) Delayed development of retinoblastoma associated with loss of a maternal allele on chromosome 13. Int. J. Cancer, 64, 3-8.
20. [20] Friend, S. (1994) p53: a glimpse at the puppet behind the shadow play. Science, 265, 334-335.
21. [21] Dameron, K.M., Volpert, O.V., Tainsky, M.A. and Bouck, N. (1994) Control of angiogenesis in fibroblasts by p53 regulation of Thrombospondin-1. Science, 265, 1582-1584.
22. [22] Kieser, A., Weich, H.A., Brandner, G., Marme, D. and Koich, W. (1994) Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene, 9, 963-969.
23. [23] Vogel, F. (1979) Genetics of retinoblastoma. Hum. Genet., 52, 1-54.
24. [24] Shimizu, T., Toguchida, J., Kato, M.V., Kaneko, A., Ishizaki, K. and Sasaki, M.S. (1994) Detection of mutations of the RB1 gene in retinoblastoma patients using exon-by-exon PCR-SSCP analysis. Am. J. Hum. Genet., 54, 793-800.